Home / Insurance / Does Cigna Cover Wegovy? Insurance Guide 2026
MC
Reviewed by Marcus Chen Updated February 20, 2026

Does Cigna Cover Wegovy? Insurance Guide 2026

Bold opening

As a clinical pharmacist specializing in metabolic health, I frequently encounter patients asking, “Does Cigna cover Wegovy?” The answer is nuanced—coverage depends on medical necessity, plan specifics, and FDA-approved indications. Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist approved for chronic weight management and, in lower doses (as Ozempic), for type 2 diabetes. Since its 2021 FDA approval, Wegovy has revolutionized obesity treatment, but insurance coverage remains inconsistent. This guide breaks down Cigna’s policies, costs, and appeals processes to help you navigate access to Wegovy in 2026.

Does Cigna Cover Wegovy for Diabetes?

Cigna typically covers Wegovy for type 2 diabetes under its Ozempic (semaglutide 1 mg or 2 mg) formulary listing, but Wegovy’s 2.4 mg dose is explicitly approved for obesity. For diabetes, Cigna’s coverage aligns with FDA guidelines, requiring:

  • A diagnosis of type 2 diabetes (HbA1c ≥6.5% or fasting glucose ≥126 mg/dL).
  • Failure of first-line therapies (e.g., metformin) or contraindications to other agents.
  • Prior authorization (PA) demonstrating medical necessity.

However, Wegovy itself is rarely covered for diabetes alone, as Ozempic is the preferred semaglutide formulation. If a patient requires the higher Wegovy dose for weight-related diabetes complications (e.g., BMI ≥30 kg/m² with poor glycemic control), Cigna may approve it under a weight-management exception. Documentation from an endocrinologist or primary care provider (PCP) is critical. In 2026, Cigna’s diabetes coverage for Wegovy remains limited, so patients should confirm their plan’s formulary or explore Ozempic as an alternative.

Does Cigna Cover Wegovy for Weight Loss?

Cigna does cover Wegovy for chronic weight management, but eligibility is strict. To qualify, patients must meet the FDA’s criteria:

  • BMI ≥30 kg/m² or BMI ≥27 kg/m² with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, obstructive sleep apnea).
  • Documented failure of lifestyle interventions (e.g., diet/exercise for ≥6 months).

Cigna’s 2026 policies require prior authorization (PA), which mandates:

  1. A letter of medical necessity from a physician (PCP, endocrinologist, or obesity specialist).
  2. Proof of participation in a supervised weight-loss program (e.g., Cigna’s own Healthy Rewards or a physician-led plan).
  3. Baseline and follow-up BMI measurements.

Coverage varies by plan tier. Fully insured Cigna plans (e.g., employer-sponsored) are more likely to include Wegovy, while self-funded or high-deductible plans may exclude it. Medicare and Medicaid (via state programs) rarely cover Wegovy for weight loss, but some Cigna Medicare Advantage plans may offer limited coverage. Always verify with Cigna’s formulary tool or customer service.

How Much Does Wegovy Cost With Cigna?

Without insurance, Wegovy costs $1,349–$1,600 per month (2026 pricing). With Cigna coverage, out-of-pocket costs depend on:

  • Plan type (e.g., PPO vs. HMO).
  • Deductible status (high-deductible plans may require full payment until the deductible is met).
  • Copay/coinsurance (typically $50–$150 per month for Tier 3 medications).

Cigna classifies Wegovy as a Tier 3 or Tier 4 drug, meaning higher cost-sharing. For example:

  • Bronze plans: 50% coinsurance (patient pays ~$675/month until deductible is met).
  • Silver/Gold plans: $75–$100 copay after deductible.
  • Platinum plans: $50 copay with no deductible.

Wegovy’s savings programs (e.g., NovoCare) may reduce costs to $25/month for commercially insured patients, but Cigna enrollees must confirm eligibility. Some Cigna plans also offer preferred pharmacy networks (e.g., CVS Caremark) with lower copays. Always check your Explanation of Benefits (EOB) or use Cigna’s cost estimator tool before filling a prescription.

Wegovy Prior Authorization for Cigna

Cigna requires prior authorization (PA) for Wegovy in nearly all cases. The PA process ensures medical necessity and prevents off-label use. To obtain approval:

  1. Physician submits a PA request via Cigna’s online portal or fax, including:
    • Patient’s BMI history (current and past measurements).
    • List of failed weight-loss interventions (e.g., diet, exercise, other medications).
    • Relevant comorbidities (e.g., hypertension, prediabetes).
    • Lab results (e.g., HbA1c, lipid panel).
  2. Cigna reviews the request (typically 5–10 business days).
  3. Approval or denial is communicated to the provider.

Common PA denials occur due to:

  • Incomplete documentation (e.g., missing BMI history).
  • Lack of proof of lifestyle intervention failure.
  • BMI below the FDA threshold (e.g., <27 kg/m² without comorbidities).

If denied, providers can appeal with additional evidence (e.g., sleep study results for OSA). Cigna may also require step therapy, mandating trials of less expensive drugs (e.g., phentermine) before approving Wegovy. Patients should work closely with their prescriber to streamline the PA process.

How to Get Cigna to Cover Wegovy

Securing Cigna coverage for Wegovy requires a proactive, multi-step approach:

  1. Confirm eligibility: Ensure your BMI and comorbidities meet FDA/Cigna criteria.
  2. Enroll in a weight-loss program: Cigna often requires participation in a supervised program (e.g., WW, Noom, or a physician-led plan).
  3. Obtain a detailed letter of medical necessity: Your doctor should document:
    • Duration of obesity (e.g., “10+ years”).
    • Failed interventions (e.g., “6 months of diet/exercise with <5% weight loss”).
    • Comorbidities (e.g., “hypertension uncontrolled on 3 medications”).
  4. Submit prior authorization (PA): Your provider must file the PA with Cigna, including all supporting documents.
  5. Follow up: If denied, request a peer-to-peer review with a Cigna medical director.

Pro tip: Some Cigna plans offer weight-management incentives (e.g., reduced copays for completing health coaching). Ask your HR department or Cigna representative about plan-specific perks. If Wegovy is denied, consider appealing with a letter from a specialist (e.g., endocrinologist or obesity medicine physician).

What to Do If Cigna Denies Wegovy

If Cigna denies Wegovy, don’t panic—appeals work. Here’s how to fight the decision:

  1. Request the denial reason: Cigna must provide a written explanation (e.g., “BMI too low” or “missing documentation”).
  2. Gather additional evidence:
    • New lab results (e.g., updated HbA1c or lipid panel).
    • Letters from specialists (e.g., cardiologist for obesity-related heart disease).
    • Photos or medical records documenting weight-related complications (e.g., joint pain, mobility issues).
  3. File a Level 1 appeal: Submit the new evidence to Cigna within 60 days of denial. Cigna must respond within 30 days (or 72 hours for urgent cases).
  4. Escalate to Level 2 (external review): If denied again, request an independent review organization (IRO) to reassess the case. This is legally binding in most states.
  5. Explore patient assistance programs: Novo Nordisk’s Wegovy Savings Card may reduce costs to $25/month for eligible patients, even if insurance denies coverage.

Success rates: Studies show ~40% of GLP-1 appeals succeed with strong documentation. Persistence pays off—don’t give up after the first denial.

Cigna Alternatives If Wegovy Is Not Covered

If Cigna denies Wegovy, consider these alternatives:

  1. Other GLP-1 agonists:
    • Zepbound (tirzepatide): A dual GIP/GLP-1 agonist with superior weight-loss results (up to 20% body weight). Some Cigna plans cover it for obesity.
    • Saxenda (liraglutide): Another FDA-approved weight-loss drug, but less effective than Wegovy (~5–10% weight loss).
  2. Non-GLP-1 medications:
    • Qsymia (phentermine/topiramate): A stimulant/appetite suppressant combo, often covered by Cigna.
    • Contrave (naltrexone/bupropion): An opioid antagonist/antidepressant with weight-loss benefits.
  3. Clinical trials: Novo Nordisk and Eli Lilly frequently recruit for Wegovy/Zepbound studies, offering free medication.
  4. Cash-pay discounts: Some pharmacies (e.g., Mark Cuban Cost Plus Drugs) offer Wegovy at reduced prices (~$1,000/month).
  5. Lifestyle interventions: Cigna’s Healthy Rewards program may cover WW (Weight Watchers) or Noom at no cost.

Key takeaway: If Wegovy is denied, work with your doctor to explore covered alternatives or patient assistance programs before paying out of pocket.

Frequently Asked Questions

Does Cigna cover Wegovy for weight loss?

Yes, but only if you meet FDA criteria (BMI ≥30 or ≥27 with comorbidities) and complete prior authorization. Cigna requires proof of failed lifestyle interventions and may mandate participation in a weight-loss program. Coverage varies by plan, so check your formulary.

How much is the Wegovy copay with Cigna?

Copays range from $50–$150/month, depending on your plan tier. High-deductible plans may require full payment (~$1,349/month) until the deductible is met. Use Cigna’s cost estimator tool or ask your pharmacy for exact pricing.

Can I appeal if Cigna denies Wegovy?

Absolutely. Request the denial reason, gather additional evidence (e.g., specialist letters, lab results), and file a Level 1 appeal within 60 days. If denied again, escalate to an external review. Many appeals succeed with strong documentation.

Disclaimer from Marcus Chen, PharmD: The information in this article is based on Cigna’s 2026 policies and clinical guidelines. Coverage varies by plan, and individual circumstances may differ. Always consult your Cigna representative, prescriber, or pharmacist for personalized advice. This article is for informational purposes only and does not constitute medical or legal guidance.